Skip to Content
19

Abiomed

Courtesy of Abiomed
  • Previous Rank-
  • Revenue 3 Yr Annual Growth Rate33%
  • Revenue 3 Yr Growth Rank42
  • EPS 3 Yr Annual Growth Rate64%
  • EPS 3 Yr Growth Rank31
  • Total Return 3 Yr Annual Rate34%
  • Total Return 3 Yr Rank32
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Industry
Medical Products & Equipment
Sector
Health Care
Current Streak1
Years on List4
CEO
Michael Minogue
Websitehttps://www.abiomed.com
Country
U.S.
Headquarters
Danvers, Mass.
Ticker
ABMD
Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.

Revenue, Net Income

Revenue past four quarters ($M)$769
Net Income past four quarters ($M)$259
Market Value as of June 28, 2019 ($M)$11,796

Growth Rates and Ranks

Revenue 3 Yr Growth Rank42
Revenue 3 Yr Annual Growth Rate33%
EPS 3 Yr Growth Rank31
EPS 3 Yr Annual Growth Rate64%
Total Return 3 Yr Rank32
Total Return 3 Yr Annual Rate34%
Beat S&P 500 3 Yr Return (14.2%)
yes